Boston Scientific Gears Up for Major Healthcare Conferences in Late 2025
- Boston Scientific will participate in two major healthcare conferences in late 2025, showcasing medical technology innovations.
- Key executives will host Q&A sessions to discuss advancements and initiatives, focusing on cardiology and overall healthcare impact.
- The company's commitment to innovation aims to improve patient health and reduce healthcare costs across various medical specialties.
Boston Scientific Prepares for Key Healthcare Conferences in Late 2025
Boston Scientific Corporation is set to participate in two major healthcare conferences in November and December 2025, showcasing its commitment to innovation in the medical technology sector. On November 18, Kenneth Stein, M.D., the company's senior vice president and global chief medical officer, along with Lauren Tengler, vice president of Investor Relations, will host a 30-minute Q&A session at Wolfe Research's 7th Annual Healthcare Conference. This event, scheduled to begin at 8:00 a.m. ET, aims to engage stakeholders and discuss Boston Scientific's latest advancements and strategic directions.
Following this, on December 2, Joe Fitzgerald, executive vice president and group president of Cardiology, and Janar Sathananthan, M.D., chief medical officer for Interventional Cardiology Therapies, will take part in a 40-minute Q&A session at Citi's 2025 Global Healthcare Conference. Starting at 9:00 a.m. ET, this session will delve deeper into the company’s initiatives in the cardiology sector, emphasizing Boston Scientific's role in addressing critical healthcare needs through innovative medical solutions. Both sessions will be live-streamed and available for replay on Boston Scientific's investor relations website, allowing broader access to insights shared during these discussions.
Boston Scientific's participation in these conferences reflects its ongoing commitment to improving patient health through cutting-edge technology. With over 45 years of experience, the company develops a diverse range of medical devices and therapies that cater to various specialties, including cardiovascular, respiratory, digestive, oncological, neurological, and urological conditions. This dedication to innovation not only addresses unmet clinical needs but also seeks to minimize healthcare costs, making Boston Scientific a pivotal player in the evolving landscape of medical technology.
In addition to the upcoming conferences, Boston Scientific continues to emphasize transparency and engagement with its stakeholders. Interested parties can find more information regarding the company and its products on its official website or through its LinkedIn page. By fostering open communication, Boston Scientific aims to strengthen its relationships with investors, healthcare providers, and patients alike, ensuring that they remain at the forefront of medical innovation.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

